CONFERENCE UPDATE: The abstract is available for Repare Therapeutics' presentation at ESMO GI from the Phase 1 MINOTAUR trial evaluating lunresertib in combination with FOLFIRI. Learn more here: https://lnkd.in/ebPvugmb #precisiononcology #syntheticlethality #clinicaltrials
Looking forward to this!
Really encouraging. Best Wishes for the journey ahead.
Innovative Leadership in Life Sciences & Technology Talent Solutions: Founder & CEO of Recruits Lab & BioJobs Lab, Driving Organizational Success through Cutting-Edge Recruitment Strategies
2moCongratulations on sharing the abstract for your presentation at ESMO GI, Repare Therapeutics! The Phase 1 MINOTAUR trial's evaluation of lunresertib in combination with FOLFIRI sounds promising in advancing precision oncology. Wishing you great success as you continue to contribute to the field of synthetic lethality and clinical trials. Looking forward to learning more about your findings! 🌟 #PrecisionOncology #ClinicalResearch #ESMOGI